Premature Ejaculation Treatment
Premature ejaculation should be treated with either selective serotonin reuptake inhibitors (SSRIs) or topical anesthetics as first-line pharmacotherapy, with the choice based on patient preference for daily versus on-demand dosing. 1
Diagnostic Essentials
Before initiating treatment, obtain a focused sexual history addressing:
- Ejaculatory latency time (self-estimated is acceptable)
- Perceived control over ejaculation
- Distress level in patient and partner
- Whether PE is lifelong (primary) or acquired (secondary)
- Rule out concurrent erectile dysfunction - if present, treat ED first as PE often resolves 1
No laboratory testing is required unless history suggests underlying medical conditions 2.
First-Line Pharmacotherapy
SSRIs (Off-Label Use)
Paroxetine 20 mg daily is the most effective SSRI option based on available evidence 1. Alternative regimens include:
Daily dosing (preferred for frequent sexual activity):
- Paroxetine: 10-40 mg/day (20 mg most effective)
- Sertraline: 25-200 mg/day
- Fluoxetine: 5-20 mg/day
- Clomipramine: 25-50 mg/day
On-demand dosing (for infrequent sexual activity):
- Paroxetine: 20 mg taken 3-4 hours pre-intercourse
- Sertraline: 50 mg taken 4-8 hours pre-intercourse
- Clomipramine: 25 mg taken 4-24 hours pre-intercourse
Critical caveat: None of these medications are FDA-approved for PE. Patients must understand this is off-label use. Common side effects include nausea, dry mouth, drowsiness, and reduced libido. Rare but serious risks include serotonin syndrome when combined with other serotonergic drugs 1.
Topical Anesthetics
Lidocaine 2.5%/prilocaine 2.5% cream (EMLA) applied 20-30 minutes before intercourse significantly increases ejaculatory latency 1.
Application technique: Apply to glans penis, consider using condom during initial penetration, then remove condom and wash residual cream to prevent partner numbness. Prolonged application (>30-45 minutes) may cause erectile difficulties 1.
The 2025 EAU guidelines specifically recommend lidocaine 150mg/mL/prilocaine 50mg/mL spray for primary PE 2, and recent French recommendations support this as well 3.
Dapoxetine (Where Available)
Dapoxetine 30 mg on-demand is the only FDA-approved medication specifically for PE in some countries (not FDA-approved in the United States). Network meta-analysis identifies dapoxetine 30 mg as having the highest likelihood of being the "best" treatment with favorable efficacy-to-side-effect ratio 4. The 60 mg dose increases efficacy but also adverse events 4.
Combination Therapy
For patients with inadequate response to monotherapy:
- Combine dapoxetine with topical lidocaine/prilocaine 3
- Combine SSRI with topical anesthetic 1
- If concurrent ED exists, add PDE5 inhibitor (sildenafil, tadalafil) which may enhance SSRI efficacy 1, 5
Treatment Duration and Expectations
PE typically recurs when medication is stopped - patients should expect ongoing therapy rather than cure 1. Start SSRIs at lowest effective dose and titrate based on response and tolerability. Some clinicians use a "loading period" of daily dosing before switching to on-demand regimen 1.
Adjunctive Approaches
Psychosexual counseling should be offered to all patients and combined with pharmacotherapy when possible 3. Behavioral techniques (stop-start, squeeze) can augment medical therapy but are insufficient as monotherapy for most patients.
What NOT to Do
- Do not perform neurectomy or penile prosthesis implantation - risks far outweigh benefits 1
- Do not routinely recommend circumcision or frenuloplasty for PE 3
- Avoid tramadol and α-1 blockers as routine PE treatments due to insufficient evidence and safety concerns 3
- Do not use nefazodone, citalopram, or fluvoxamine - studies show these are ineffective for PE 1
Safety Priority
Because PE is not life-threatening, safety must be the primary consideration 1. All pharmacologic options carry risks that must be weighed against benefits, particularly given the off-label nature of most treatments in the United States.